In Vitro Assay Services

Delivering high-quality, human-relevant data to answer your most complex toxicology and product safety questions.

In vitro data that

reflects human biology

As regulatory and consumer pressure grows to reduce reliance on animal testing, scientists need advanced in vitro models that better reflect real human biology. LifeNet Health® LifeSciences provides assay services built on ethically sourced, donor-derived samples and first-in-class New Approach Methodologies (NAMs) and complex in vitro assays that deliver more predictive, human-relevant data.


Our expert team will help you identify the right assays to de-risk development, perform due diligence to support safety claims, and inspire regulatory confidence.

Comprehensive in vitro assay services for

research and regulatory submission

No image
Multi-Organ Studies Using a Human Dynamic MPS Platform

Capture superior, human-relevant data regarding systemic impacts of a compound across multiple 2D and 3D cells and tissues, simultaneously.
More

No image
TruVivo Advanced Model

TruVivo® is the first and only 2D+ hepatic system to provide human-relevant, reliable results in an easy-to-use format. With prequalified primary human cells combined to mimic the microarchitecture and functionality of the human liver, TruVivo excels in cytotoxicity studies, ADME/DMPK assays, or to represent the liver in our multi-organ platform screening service.

More

Didn't find what you're looking for?

We can customize in vitro assay service studies to meet your specific needs. Let’s find a solution for your project.

Why work with us?

Tissues recovered from donors with known demographics, including age, sex, BMI, ethnicity, cause of death, and social medical history

Study designs are suitable for IND and regulatory submissions

Access to innovative new approach methods and the highest performing cells, biospecimens, and organotypic tissues

High-quality services with fast turnaround from completion of study to report

Our facilities are compliant with GLP practices and Good In Vitro Method Practices (OECD 286), and align with US FDA and US EPA GLP specifications

Actively reducing reliance on animal testing by performing bridging studies between currently accepted regulatory test methods and new approach methods

Resources